Effects of roxithromycin on the production of lipase and neutrophil chemotactic factor by Propionibacterium acnes

被引:13
作者
Akamatsu, H
Tomita, T
Horio, T
机构
[1] Fujita Hlth Univ, Sch Med, Dept Dermatol, Toyoake, Aichi 4701192, Japan
[2] ICAM Co Ltd, Tokyo, Japan
[3] Kansai Med Univ, Dept Dermatol, Osaka, Japan
关键词
roxithromycin; Propionibacterium acnes; lipase; neutrophil chemotactic factor; acne;
D O I
10.1159/000063358
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background: The macrolide antibiotic roxithromycin is effective against acne associated with inflammation, but the mechanism by which this is achieved has not been clarified. Objective:We studied the effects of roxithromycin on the production of lipase and neutrophil chemotactic factor by Propionibacterium acnes in vitro. Results: Roxithromycin significantly inhibited the production of lipase and neutrophil chemotactic factor by P. acnes at a concentration one eighth of the MIC, at which the growth curve of P. acnes is not affected. Conclusion: One mechanism of the effectiveness of roxithromycin in acne therapy is thought to be the inhibition of bacterial lipase and neutrophil chemotactic factor production by P. acnes. Copyright (C) 2002 S. Karger AG, Basel.
引用
收藏
页码:277 / 280
页数:4
相关论文
共 15 条
[1]   The effect of roxithromycin on the generation of reactive oxygen species in vitro [J].
Akamatsu, H ;
Nishijima, S ;
Akamatsu, M ;
Kurokawa, I ;
Sasaki, H ;
Asada, Y .
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 1996, 24 (01) :27-32
[2]   EFFECTS OF SUBMINIMAL INHIBITORY CONCENTRATIONS OF MINOCYCLINE ON NEUTROPHIL CHEMOTACTIC FACTOR PRODUCTION IN COMEDONAL BACTERIA, NEUTROPHIL PHAGOCYTOSIS AND OXYGEN-METABOLISM [J].
AKAMATSU, H ;
NIWA, Y ;
KUROKAWA, I ;
MASUDA, R ;
NISHIJIMA, S ;
ASADA, Y .
ARCHIVES OF DERMATOLOGICAL RESEARCH, 1991, 283 (08) :524-528
[3]  
AKAMATSU H, 1999, MANUAL TREATMENT DER, P1
[4]  
AKAMATSU H, 1999, MANUAL TREATMENT DER, P13
[5]   Clinical evaluation of roxithromycin in patients with acne [J].
Akamatsu, M ;
Nishijima, S ;
Akamatsu, R ;
Kurokawa, I ;
Asada, Y .
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 1996, 24 (01) :109-114
[6]  
ARATA J, 1997, NISHINIHON J DERMATO, V59, P444
[7]   INVITRO COMPARISON OF THE ACTIVITY OF RU-28965, A NEW MACROLIDE, WITH THAT OF ERYTHROMYCIN AGAINST AEROBIC AND ANAEROBIC-BACTERIA [J].
BARLAM, T ;
NEU, HC .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1984, 25 (04) :529-531
[9]   ANTIBACTERIAL ACTIVITY OF ROXITHROMYCIN - A LABORATORY EVALUATION [J].
CHANTOT, JF ;
BRYSKIER, A ;
GASC, JC .
JOURNAL OF ANTIBIOTICS, 1986, 39 (05) :660-668
[10]   INVITRO EVALUATION OF 3 NEW MACROLIDE ANTI-MICROBIAL AGENTS, RU28965, RU29065, AND RU29702, AND COMPARISONS WITH OTHER ORALLY-ADMINISTERED DRUGS [J].
JONES, RN ;
BARRY, AL ;
THORNSBERRY, C .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1983, 24 (02) :209-215